Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate Cancer

2011307 citationsJournal Articlebronze Open Access

Authors

Paul L. Nguyen · Dana-Farber Brigham Cancer Center

Xiangmei Gu · Dana-Farber Brigham Cancer Center

Stuart R. Lipsitz · Dana-Farber Brigham Cancer Center

Toni K. Choueiri · Dana-Farber Brigham Cancer Center

Wesley W. Choi · Dana-Farber Brigham Cancer Center

Lei Yin · Dana-Farber Brigham Cancer Center

Karen E. Hoffman

Abstract

Costlier prostate cancer therapies were rapidly and widely adopted, resulting in additional national spending of more than $350 million among men diagnosed in 2005 and suggesting the need for comparative effectiveness research to weigh their costs against their benefits.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life Economic and Financial Impacts of Cancer Statistical Methods in Clinical Trials

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 29, Issue 12, pp. 1517-1524

DOI: 10.1200/jco.2010.31.1217

Field-Weighted Citation Impact: 150.57